CA1332148C - Dispositif d'ecoulement capillaire et methode de dosage par double capture - Google Patents

Dispositif d'ecoulement capillaire et methode de dosage par double capture

Info

Publication number: CA1332148C
Authority: CA; Canada
Prior art keywords: particles; interest; antigen; antibody; nonmagnetic
Prior art date: 1988-05-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 598590

Other languages

English (en)

Inventor

Obsidiana Abril

Sara Bauminger

Daniel E. Cox

Lisa Shinefeld

Bruce P. Neri

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cambridge Biotech Corp

Original Assignee

Cambridge Biotech Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-04

Filing date

1989-05-03

Publication date

1994-09-27

1989-05-03 Application filed by Cambridge Biotech Corp filed Critical Cambridge Biotech Corp

1994-09-27 Application granted granted Critical

1994-09-27 Publication of CA1332148C publication Critical patent/CA1332148C/fr

2011-09-27 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000003556 assay Methods 0.000 title claims abstract description 30
239000002245 particle Substances 0.000 claims abstract description 290
239000012491 analyte Substances 0.000 claims abstract description 86
230000009870 specific binding Effects 0.000 claims abstract description 59
238000003018 immunoassay Methods 0.000 claims abstract description 20
239000000427 antigen Substances 0.000 claims description 149
102000036639 antigens Human genes 0.000 claims description 149
108091007433 antigens Proteins 0.000 claims description 149
238000000034 method Methods 0.000 claims description 71
239000006249 magnetic particle Substances 0.000 claims description 61
239000000203 mixture Substances 0.000 claims description 48
239000011541 reaction mixture Substances 0.000 claims description 24
230000027455 binding Effects 0.000 claims description 21
239000007788 liquid Substances 0.000 claims description 19
229940079593 drug Drugs 0.000 claims description 11
239000003814 drug Substances 0.000 claims description 11
KZFBHCCLJSAHBQ-UHFFFAOYSA-N Benzoylecgonine Natural products CN1C2CCC1C(C(C2)OC(=C)c3ccccc3)C(=O)O KZFBHCCLJSAHBQ-UHFFFAOYSA-N 0.000 claims description 9
GVGYEFKIHJTNQZ-RFQIPJPRSA-N ecgonine benzoate Chemical compound O([C@@H]1[C@@H]([C@H]2CC[C@@H](C1)N2C)C(O)=O)C(=O)C1=CC=CC=C1 GVGYEFKIHJTNQZ-RFQIPJPRSA-N 0.000 claims description 9
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims description 6
229960003920 cocaine Drugs 0.000 claims description 3
239000011343 solid material Substances 0.000 claims 8
239000002207 metabolite Substances 0.000 claims 5
238000004891 communication Methods 0.000 claims 4
230000006854 communication Effects 0.000 claims 4
230000000295 complement effect Effects 0.000 claims 2
239000000523 sample Substances 0.000 description 104
239000003153 chemical reaction reagent Substances 0.000 description 26
239000004816 latex Substances 0.000 description 25
229920000126 latex Polymers 0.000 description 25
230000004520 agglutination Effects 0.000 description 23
239000003446 ligand Substances 0.000 description 19
239000000463 material Substances 0.000 description 16
239000000872 buffer Substances 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 12
238000001514 detection method Methods 0.000 description 12
150000003839 salts Chemical class 0.000 description 12
239000000126 substance Substances 0.000 description 10
239000011148 porous material Substances 0.000 description 7
230000003993 interaction Effects 0.000 description 6
150000001540 azides Chemical class 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
210000002700 urine Anatomy 0.000 description 5
239000003086 colorant Substances 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
-1 red blood cells Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
101000662009 Homo sapiens UDP-N-acetylglucosamine pyrophosphorylase Proteins 0.000 description 3
102100037921 UDP-N-acetylglucosamine pyrophosphorylase Human genes 0.000 description 3
238000004040 coloring Methods 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
241000894007 species Species 0.000 description 3
239000000725 suspension Substances 0.000 description 3
HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
101710098119 Chaperonin GroEL 2 Proteins 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
102000015636 Oligopeptides Human genes 0.000 description 2
108010038807 Oligopeptides Proteins 0.000 description 2
238000000149 argon plasma sintering Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
239000011521 glass Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000000670 ligand binding assay Methods 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000012071 phase Substances 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
239000011535 reaction buffer Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
OGNVQLDIPUXYDH-ZPKKHLQPSA-N (2R,3R,4S)-3-(2-methylpropanoylamino)-4-(4-phenyltriazol-1-yl)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(O)=O)=C[C@@H]1N1N=NC(C=2C=CC=CC=2)=C1 OGNVQLDIPUXYDH-ZPKKHLQPSA-N 0.000 description 1
239000004925 Acrylic resin Substances 0.000 description 1
229920000178 Acrylic resin Polymers 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
230000004523 agglutinating effect Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000009830 antibody antigen interaction Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
238000002820 assay format Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000010408 film Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000000696 magnetic material Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000003973 paint Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920006267 polyester film Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000010409 thin film Substances 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Pathology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Automatic Analysis And Handling Materials Therefor (AREA)
Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA 598590 1988-05-04 1989-05-03 Dispositif d'ecoulement capillaire et methode de dosage par double capture Expired - Fee Related CA1332148C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18998388A	1988-05-04	1988-05-04
US189,983		1988-05-04

Publications (1)

Publication Number	Publication Date
CA1332148C true CA1332148C (fr)	1994-09-27

Family

ID=22699579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 598590 Expired - Fee Related CA1332148C (fr)	1988-05-04	1989-05-03	Dispositif d'ecoulement capillaire et methode de dosage par double capture

Country Status (4)

Country	Link
EP (1)	EP0413758A1 (fr)
JP (1)	JPH05504828A (fr)
CA (1)	CA1332148C (fr)
WO (1)	WO1989011102A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2684186B1 (fr) *	1991-11-25	1994-02-25	Pasteur Sanofi Diagnostics	Trousse pour le denombrement rapide des granulocytes, et procede utilisant ladite trousse.
SE9500184D0 (sv) *	1995-01-20	1995-01-20	Pharmacia Ab	Analysmetod som utnyttjar biospecifika affinitetsreaktioner och märkt reaktant samt reagens att användas i föredragen utförandeform
US5876935A (en) *	1997-01-08	1999-03-02	Dade Behring Inc.	Luminescent specific binding assay
WO2007123345A1 (fr) *	2006-04-21	2007-11-01	Peoplebio, Inc.	Procédé de détection différentielle d'une forme multimère et d'une forme monomère dans des polypeptides formant des multimères par interactions tridimensionnelles
EP3141901B1 (fr)	2007-10-04	2018-12-12	PHC Holdings Corporation	Dispositif d'analyse et appareil et procédé d'analyse l'utilisant
JP5348901B2 (ja) *	2008-02-01	2013-11-20	パナソニック株式会社	分析用デバイスを用いた分析方法
CN110346556B (zh) *	2019-07-15	2023-02-17	深圳海思安生物技术有限公司	一种液体检测试剂及其使用方法
CN110346558B (zh) *	2019-07-15	2023-03-31	深圳海思安生物技术有限公司	一种检测试剂盒的使用方法
CN110346557B (zh) *	2019-07-15	2023-03-31	深圳海思安生物技术有限公司	一种检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4115535A (en) *	1977-06-22	1978-09-19	General Electric Company	Diagnostic method employing a mixture of normally separable protein-coated particles
US4596695A (en) *	1984-09-10	1986-06-24	Cottingham Hugh V	Agglutinographic reaction chamber
FI850481A0 (fi) *	1985-02-06	1985-02-06	Labsystems Oy	Foerfarande foer bestaemning av motmedel eller antigener.
FI851702A0 (fi) *	1985-04-29	1985-04-29	Labsystems Oy	Foerfarande och anordning foer utfoering immunobestaemningar.
US4710472A (en) *	1985-09-25	1987-12-01	The United States Of America As Represented By The Secretary Of The Navy	Magnetic separation device

1989
- 1989-05-02 JP JP1505949A patent/JPH05504828A/ja active Pending
- 1989-05-02 WO PCT/US1989/001862 patent/WO1989011102A1/fr not_active Ceased
- 1989-05-02 EP EP19890906274 patent/EP0413758A1/fr not_active Withdrawn
- 1989-05-03 CA CA 598590 patent/CA1332148C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH05504828A (ja)	1993-07-22
EP0413758A1 (fr)	1991-02-27
WO1989011102A1 (fr)	1989-11-16

Legal Events

Date	Code	Title	Description
1998-09-28	MKLA	Lapsed

Publication	Publication Date	Title
US5145784A (en)	1992-09-08	Double capture assay method employing a capillary flow device
US7285424B2 (en)	2007-10-23	Membrane-based assay devices
JP2510932B2 (ja)	1996-06-26	試料中における生物学的物質の存在を決定する方法及び装置
CA2495190C (fr)	2012-12-18	Dispositif de dosage se fondant sur la fluidique
EP1532448B1 (fr)	2008-02-20	Systeme d'auto-etalonnage pour un dosage de liaison magnetique
EP0351857A2 (fr)	1990-01-24	Méthode d'essai immunologique utilisant des particules magnétiques comme marqueurs
MX2007000920A (es)	2007-04-13	Dispositivo de flujo lateral para la deteccion de patogenos grandes.
KR960702616A (ko)	1996-04-27	세포 결정을 위한 면역분석법(immunoassay for determination of cells)
PL196464B1 (pl)	2008-01-31	Analityczne urządzenie chromatograficzne oraz sposób wykrywania obecności przedmiotu analizy w próbce krwi
CA1332148C (fr)	1994-09-27	Dispositif d'ecoulement capillaire et methode de dosage par double capture
JP2001221799A (ja)	2001-08-17	判定部を複数有する被検物質の測定器具及び測定方法
JPH08201391A (ja)	1996-08-09	マ−カ−粒子を用いた免疫学的測定方法
JPH09229936A (ja)	1997-09-05	磁性粒子を用いる被検物質の測定方法並びに該方法に使用する担体及び測定器具
US20050130223A1 (en)	2005-06-16	Method, system and kit for detecting an analyte in a sample
JP2000131320A (ja)	2000-05-12	特異的結合物質固定粒子を用いる被検物質の測定方法
JPH06148188A (ja)	1994-05-27	免疫学的再検査方法
JPH10227794A (ja)	1998-08-25	粒子を使用する被検物質の測定方法
JPH11326327A (ja)	1999-11-26	粒子を使用する被検物質の測定方法及び測定器具
JPH11287803A (ja)	1999-10-19	粒子を使用する被検物質の測定器具及び測定方法